4//SEC Filing
McDowell Caryn Gordon 4
Accession 0001479290-20-000004
CIK 0001479290other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 6:46 PM ET
Size
5.0 KB
Accession
0001479290-20-000004
Insider Transaction Report
Form 4
McDowell Caryn Gordon
SVP, GC & Secretary
Transactions
- Other
Common Stock
2019-12-31$10.82/sh+382$4,133→ 24,317 total
Footnotes (1)
- [F1]These shares were acquired by Mrs. McDowell under the Issuer's 2014 Employee Stock Purchase Plan (the "Plan") on December 31, 2019 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Mrs. McDowell purchased the maximum number of shares allowable under the Issuer's Plan and Internal Revenue Code Section 423(b)(8) for the period ended December 31, 2019.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001674232
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 6:46 PM ET
- Size
- 5.0 KB